Tianhui Yuan | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Dr. Tianhui Yuan | Medicine and Health Sciences | Best Researcher Award

Associate Director | The First Affiliated Hospital of Guangzhou University of Medicine | China

Prof. Dr. Tianhui Yuan is a distinguished physician-scientist whose educational journey culminated in the M.D. and a Ph.D. in integrated medicine and cardiovascular science (with doctoral training at a leading university), and she currently serves as Chief Physician, Doctoral Supervisor, and Associate Director of her department while also holding a Visiting Scholar appointment in the United States. Over her career, she has held progressive roles in clinical practice, laboratory research, and academic leadership in integrative Chinese and Western medicine. Her professional experience spans directing clinical care units in cardiovascular medicine, mentoring doctoral and postdoctoral researchers, coordinating international research collaborations, and representing her institution in health policy and traditional medicine networks. Her research interests lie at the interface between traditional Chinese medicine and modern cardiovascular disease therapy, particularly focusing on mechanisms and therapeutic strategies for heart failure, cardiomyopathy, coronary artery disease, hypertension, arrhythmia, hyperlipidemia, and insomnia. She is skilled in experimental cardiovascular physiology, molecular biology, signaling pathway analysis, preclinical animal models, translational interventions, and clinical guideline development. She has made significant scholarly contributions: she has authored 15 documents, received 154 Citations, and holds an h-index of 7, reflecting a growing impact. Among her honors and awards, she has been selected for the Guangdong Provincial Health Commission’s “Guangdong Special Support Program” and the “Youth Talent Support Program,” and she holds recognition as a young academic leader at her university; she also serves on multiple national and international professional committees and has contributed to guideline development, patent filing (2 invention patents), software intellectual property (1 software copyright), and the authorship of 9 books. Through mentorship she has guided student teams to high distinction in innovation competitions and has been invited as a keynote speaker at major conferences like the ESC Heart Failure Congress and the International Heart Congress. Given her solid educational foundation, extensive clinical and research experience, integrative medicine focus, leadership roles, and peer-recognized contributions, Prof. Dr. Tianhui Yuan is exceptionally well positioned to advance her field further, strengthen international collaborations, expand high-impact publication outputs, and mentor the next generation of integrative cardiovascular researchers.

Profile: Scopus

Featured Publications

  1. Ma, X., … Yuan, T. (2023). Regulation of phospholipid peroxidation signaling by a traditional Chinese medicine formula to prevent myocardial ischemia. Journal Name.

  2. Dong, X., Han, X., Zhang, X., … Yuan, T. (2022). A simplified herbal formula improves cardiac function and reduces inflammation in mice through the TLR-mediated NF-κB signaling pathway. Journal Name.

  3. Yang, Z., Xian, S., Yuan, T. (2020). Dexmedetomidine-mediated regulation of miR-17-3p in H9C2 cells after hypoxia/reoxygenation injury. Journal Name.

  4. Yuan, T., Chen, Y., Zhou, X., … (2019). Effectiveness and safety of Danshen injection on heart failure: protocol for a systematic review and meta-analysis. Journal Name.

  5. Wang, L., Gao, M., Chen, J., … (2015). Resveratrol ameliorates pressure overload-induced cardiac dysfunction and attenuates autophagy in rats. Journal Name.

 

Mengting Zhang | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Ms. Mengting Zhang | Medicine and Health Sciences | Best Researcher Award

Miss | Guangdong Medical University | Hong Kong

Ms. Mengting Zhang is a highly motivated and emerging scholar in the field of Medicine and Health Sciences, currently affiliated with Guangdong Medical University, Hong Kong, where she has established herself as a promising researcher contributing significantly to global advancements in medical and clinical research. With a strong academic foundation supported by a Doctoral degree in Medicine, Ms. Zhang has cultivated a comprehensive understanding of medical sciences, pharmacology, and translational research methodologies. Her educational journey reflects a deep commitment to precision, innovation, and interdisciplinary collaboration, equipping her with the skills to integrate clinical data, biomedical insights, and analytical modeling for impactful healthcare outcomes. Throughout her professional career, Ms. Zhang has demonstrated excellence in multiple research domains, including pharmacovigilance, clinical pharmacology, oral oncology, and biomedical informatics. She has been extensively involved in projects focusing on adverse drug event detection, molecular disease pathways, and bioinformatics-based health analysis, which are central to improving patient safety and therapeutic efficacy. Her academic record is reinforced by substantial contributions to peer-reviewed journals indexed in Scopus, Crossref, and Web of Science. Ms. Zhang has authored 11 documents, received 33 citations, and holds an h-index of 4, underscoring her consistent academic influence and growing recognition in the research community. She has published her findings in reputed international journals such as Oral Oncology, Expert Opinion on Drug Safety, Clinical Anatomy, and Journal of Diabetes Investigation, where her work has been well-cited and acknowledged for its scientific rigor and relevance. Her research explores complex relationships between genetics, drug response, and oral health conditions, with a focus on integrating real-world pharmacovigilance data and molecular evidence to enhance the accuracy of clinical outcomes. Ms. Zhang’s research skills encompass advanced data analysis, systematic review techniques, visual scientometrics using CiteSpace and VOSviewer, clinical trial evaluation, and statistical modeling. Professionally, she has collaborated with national and international researchers, contributing to studies utilizing FDA adverse event reporting systems and developing visual bibliometric maps that identify emerging medical trends. Her dedication to accuracy, methodological clarity, and ethical research practices has earned her recognition as a dependable contributor to academic development. Beyond research, Ms. Zhang is engaged in mentoring, peer-reviewing, and participating in collaborative scientific platforms that promote interdisciplinary learning and global knowledge sharing. Her commitment to innovation and collaboration highlights her as a future leader in the scientific community, capable of influencing both clinical and policy-level improvements in healthcare. Ms. Zhang’s achievements have positioned her as a potential candidate for several international honors and awards in biomedical sciences, including recognitions for research excellence and contribution to pharmacological safety evaluation. In conclusion, Ms. Mengting Zhang embodies academic integrity, scientific precision, and a vision for global medical progress.

Profile:  ORCID | Scopus

Featured Publications

  1. Zhang, M. (2025). Comment on “Uncovering chromatin factor landscapes in head and neck squamous cell carcinoma.” Oral Oncology. Citations: 7.

  2. Zhang, M. (2025). Comment on “Tooth Anomalies in Patients With Nonsyndromic Orofacial Cleft: A Systematic Review and Meta‐Analysis.” Oral Diseases. Citations: 5.

  3. Zhang, M. (2025). A real-world disproportionality analysis of the FDA adverse event reporting system events for ibuprofen. Expert Opinion on Drug Safety. Citations: 8.

  4. Zhang, M. (2024). A real‐world disproportionality analysis of semaglutide: Post‐marketing pharmacovigilance data. Journal of Diabetes Investigation. Citations: 6.

  5. Zhang, M. (2024). Research advances and trends in anatomy from 2013 to 2023: A visual analysis based on CiteSpace and VOSviewer. Clinical Anatomy. Citations: 7.